IBDEI07X ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10456,2)
 ;;=^267277
 ;;^UTILITY(U,$J,358.3,10457,0)
 ;;=202.81^^52^596^61
 ;;^UTILITY(U,$J,358.3,10457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10457,1,3,0)
 ;;=3^Lymphoma,Oth Head,Face,Neck Lymphs
 ;;^UTILITY(U,$J,358.3,10457,1,4,0)
 ;;=4^202.81
 ;;^UTILITY(U,$J,358.3,10457,2)
 ;;=^267496
 ;;^UTILITY(U,$J,358.3,10458,0)
 ;;=215.9^^52^596^85
 ;;^UTILITY(U,$J,358.3,10458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10458,1,3,0)
 ;;=3^Oth Benign Neoplasm Connect Tissue
 ;;^UTILITY(U,$J,358.3,10458,1,4,0)
 ;;=4^215.9
 ;;^UTILITY(U,$J,358.3,10458,2)
 ;;=^267620
 ;;^UTILITY(U,$J,358.3,10459,0)
 ;;=224.2^^52^596^51
 ;;^UTILITY(U,$J,358.3,10459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10459,1,3,0)
 ;;=3^Lac Gland,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,10459,1,4,0)
 ;;=4^224.2
 ;;^UTILITY(U,$J,358.3,10459,2)
 ;;=^267672
 ;;^UTILITY(U,$J,358.3,10460,0)
 ;;=224.5^^52^596^96
 ;;^UTILITY(U,$J,358.3,10460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10460,1,3,0)
 ;;=3^Retina,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,10460,1,4,0)
 ;;=4^224.5
 ;;^UTILITY(U,$J,358.3,10460,2)
 ;;=^267675
 ;;^UTILITY(U,$J,358.3,10461,0)
 ;;=224.7^^52^596^28
 ;;^UTILITY(U,$J,358.3,10461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10461,1,3,0)
 ;;=3^Duct,Sac,Nasolac Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,10461,1,4,0)
 ;;=4^224.7
 ;;^UTILITY(U,$J,358.3,10461,2)
 ;;=^267677
 ;;^UTILITY(U,$J,358.3,10462,0)
 ;;=237.70^^52^596^66
 ;;^UTILITY(U,$J,358.3,10462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10462,1,3,0)
 ;;=3^Neurofibromatosis
 ;;^UTILITY(U,$J,358.3,10462,1,4,0)
 ;;=4^237.70
 ;;^UTILITY(U,$J,358.3,10462,2)
 ;;=^278264
 ;;^UTILITY(U,$J,358.3,10463,0)
 ;;=239.6^^52^596^65
 ;;^UTILITY(U,$J,358.3,10463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10463,1,3,0)
 ;;=3^Neoplasm,Brain,Unspec Nature
 ;;^UTILITY(U,$J,358.3,10463,1,4,0)
 ;;=4^239.6
 ;;^UTILITY(U,$J,358.3,10463,2)
 ;;=^16739
 ;;^UTILITY(U,$J,358.3,10464,0)
 ;;=239.81^^52^596^97
 ;;^UTILITY(U,$J,358.3,10464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10464,1,3,0)
 ;;=3^Retina/Choroid Neoplasm,Unspec Nature
 ;;^UTILITY(U,$J,358.3,10464,1,4,0)
 ;;=4^239.81
 ;;^UTILITY(U,$J,358.3,10464,2)
 ;;=^338224
 ;;^UTILITY(U,$J,358.3,10465,0)
 ;;=272.0^^52^596^48
 ;;^UTILITY(U,$J,358.3,10465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10465,1,3,0)
 ;;=3^Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,10465,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,10465,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,10466,0)
 ;;=340.^^52^596^63
 ;;^UTILITY(U,$J,358.3,10466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10466,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,10466,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,10466,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,10467,0)
 ;;=345.90^^52^596^29
 ;;^UTILITY(U,$J,358.3,10467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10467,1,3,0)
 ;;=3^Epliepsy,Unspec
 ;;^UTILITY(U,$J,358.3,10467,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,10467,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,10468,0)
 ;;=368.02^^52^596^23
 ;;^UTILITY(U,$J,358.3,10468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10468,1,3,0)
 ;;=3^Deprivation Amblyopia
 ;;^UTILITY(U,$J,358.3,10468,1,4,0)
 ;;=4^368.02
 ;;^UTILITY(U,$J,358.3,10468,2)
 ;;=^265361
 ;;^UTILITY(U,$J,358.3,10469,0)
 ;;=368.11^^52^596^103
 ;;^UTILITY(U,$J,358.3,10469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10469,1,3,0)
 ;;=3^Sudden Visual Loss
 ;;^UTILITY(U,$J,358.3,10469,1,4,0)
 ;;=4^368.11
 ;;^UTILITY(U,$J,358.3,10469,2)
 ;;=^268831
 ;;^UTILITY(U,$J,358.3,10470,0)
 ;;=368.59^^52^596^11
 ;;^UTILITY(U,$J,358.3,10470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10470,1,3,0)
 ;;=3^Color Blindness
 ;;^UTILITY(U,$J,358.3,10470,1,4,0)
 ;;=4^368.59
 ;;^UTILITY(U,$J,358.3,10470,2)
 ;;=^87408
 ;;^UTILITY(U,$J,358.3,10471,0)
 ;;=368.60^^52^596^67
 ;;^UTILITY(U,$J,358.3,10471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10471,1,3,0)
 ;;=3^Night Blindness
 ;;^UTILITY(U,$J,358.3,10471,1,4,0)
 ;;=4^368.60
 ;;^UTILITY(U,$J,358.3,10471,2)
 ;;=^83350
 ;;^UTILITY(U,$J,358.3,10472,0)
 ;;=368.9^^52^596^114
 ;;^UTILITY(U,$J,358.3,10472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10472,1,3,0)
 ;;=3^Visual Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,10472,1,4,0)
 ;;=4^368.9
 ;;^UTILITY(U,$J,358.3,10472,2)
 ;;=^124001
 ;;^UTILITY(U,$J,358.3,10473,0)
 ;;=369.00^^52^596^109
 ;;^UTILITY(U,$J,358.3,10473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10473,1,3,0)
 ;;=3^Total Blindness,Both Eyes
 ;;^UTILITY(U,$J,358.3,10473,1,4,0)
 ;;=4^369.00
 ;;^UTILITY(U,$J,358.3,10473,2)
 ;;=^15310
 ;;^UTILITY(U,$J,358.3,10474,0)
 ;;=369.01^^52^596^110
 ;;^UTILITY(U,$J,358.3,10474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10474,1,3,0)
 ;;=3^Total Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,10474,1,4,0)
 ;;=4^369.01
 ;;^UTILITY(U,$J,358.3,10474,2)
 ;;=^268861
 ;;^UTILITY(U,$J,358.3,10475,0)
 ;;=369.02^^52^596^75
 ;;^UTILITY(U,$J,358.3,10475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10475,1,3,0)
 ;;=3^One Eye-Near Total/Oth Eye-NOS
 ;;^UTILITY(U,$J,358.3,10475,1,4,0)
 ;;=4^369.02
 ;;^UTILITY(U,$J,358.3,10475,2)
 ;;=^268862
 ;;^UTILITY(U,$J,358.3,10476,0)
 ;;=369.03^^52^596^74
 ;;^UTILITY(U,$J,358.3,10476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10476,1,3,0)
 ;;=3^One Eye-Near Total/Oth Eye Total
 ;;^UTILITY(U,$J,358.3,10476,1,4,0)
 ;;=4^369.03
 ;;^UTILITY(U,$J,358.3,10476,2)
 ;;=^268863
 ;;^UTILITY(U,$J,358.3,10477,0)
 ;;=369.04^^52^596^64
 ;;^UTILITY(U,$J,358.3,10477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10477,1,3,0)
 ;;=3^Near Total Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,10477,1,4,0)
 ;;=4^369.04
 ;;^UTILITY(U,$J,358.3,10477,2)
 ;;=^268864
 ;;^UTILITY(U,$J,358.3,10478,0)
 ;;=369.06^^52^596^78
 ;;^UTILITY(U,$J,358.3,10478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10478,1,3,0)
 ;;=3^One Eye-Profound,Oth Eye-Total
 ;;^UTILITY(U,$J,358.3,10478,1,4,0)
 ;;=4^369.06
 ;;^UTILITY(U,$J,358.3,10478,2)
 ;;=^268866
 ;;^UTILITY(U,$J,358.3,10479,0)
 ;;=369.07^^52^596^77
 ;;^UTILITY(U,$J,358.3,10479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10479,1,3,0)
 ;;=3^One Eye-Profound,Oth Eye-Near
 ;;^UTILITY(U,$J,358.3,10479,1,4,0)
 ;;=4^369.07
 ;;^UTILITY(U,$J,358.3,10479,2)
 ;;=^268867
 ;;^UTILITY(U,$J,358.3,10480,0)
 ;;=369.08^^52^596^92
 ;;^UTILITY(U,$J,358.3,10480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10480,1,3,0)
 ;;=3^Profound Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,10480,1,4,0)
 ;;=4^369.08
 ;;^UTILITY(U,$J,358.3,10480,2)
 ;;=^268868
 ;;^UTILITY(U,$J,358.3,10481,0)
 ;;=369.10^^52^596^73
 ;;^UTILITY(U,$J,358.3,10481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10481,1,3,0)
 ;;=3^One Eye-Blind,Oth-Low Vision
 ;;^UTILITY(U,$J,358.3,10481,1,4,0)
 ;;=4^369.10
 ;;^UTILITY(U,$J,358.3,10481,2)
 ;;=^268870
 ;;^UTILITY(U,$J,358.3,10482,0)
 ;;=369.11^^52^596^79
 ;;^UTILITY(U,$J,358.3,10482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10482,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Blind
 ;;^UTILITY(U,$J,358.3,10482,1,4,0)
 ;;=4^369.11
 ;;^UTILITY(U,$J,358.3,10482,2)
 ;;=^268871
 ;;^UTILITY(U,$J,358.3,10483,0)
 ;;=369.12^^52^596^82
 ;;^UTILITY(U,$J,358.3,10483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10483,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Total
 ;;^UTILITY(U,$J,358.3,10483,1,4,0)
 ;;=4^369.12
 ;;^UTILITY(U,$J,358.3,10483,2)
 ;;=^268872
 ;;^UTILITY(U,$J,358.3,10484,0)
 ;;=369.13^^52^596^80
 ;;^UTILITY(U,$J,358.3,10484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10484,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Near Total
 ;;^UTILITY(U,$J,358.3,10484,1,4,0)
 ;;=4^369.13
 ;;^UTILITY(U,$J,358.3,10484,2)
 ;;=^268873
 ;;^UTILITY(U,$J,358.3,10485,0)
 ;;=369.14^^52^596^81
 ;;^UTILITY(U,$J,358.3,10485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10485,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Profound
 ;;^UTILITY(U,$J,358.3,10485,1,4,0)
 ;;=4^369.14
 ;;^UTILITY(U,$J,358.3,10485,2)
 ;;=^268874
 ;;^UTILITY(U,$J,358.3,10486,0)
 ;;=369.22^^52^596^102
 ;;^UTILITY(U,$J,358.3,10486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10486,1,3,0)
 ;;=3^Severe Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,10486,1,4,0)
 ;;=4^369.22
 ;;^UTILITY(U,$J,358.3,10486,2)
 ;;=^268882
 ;;^UTILITY(U,$J,358.3,10487,0)
 ;;=369.60^^52^596^6
 ;;^UTILITY(U,$J,358.3,10487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10487,1,3,0)
 ;;=3^Blindness,One Eye Only
 ;;^UTILITY(U,$J,358.3,10487,1,4,0)
 ;;=4^369.60
 ;;^UTILITY(U,$J,358.3,10487,2)
 ;;=^268880
 ;;^UTILITY(U,$J,358.3,10488,0)
 ;;=369.9^^52^596^115
 ;;^UTILITY(U,$J,358.3,10488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10488,1,3,0)
 ;;=3^Visual Loss NOS
 ;;^UTILITY(U,$J,358.3,10488,1,4,0)
 ;;=4^369.9
 ;;^UTILITY(U,$J,358.3,10488,2)
 ;;=^126769
 ;;^UTILITY(U,$J,358.3,10489,0)
 ;;=377.61^^52^596^20
 ;;^UTILITY(U,$J,358.3,10489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10489,1,3,0)
 ;;=3^D/O Pathways w/ Neoplasm
 ;;^UTILITY(U,$J,358.3,10489,1,4,0)
 ;;=4^377.61
 ;;^UTILITY(U,$J,358.3,10489,2)
 ;;=^269241
 ;;^UTILITY(U,$J,358.3,10490,0)
 ;;=379.02^^52^596^68
 ;;^UTILITY(U,$J,358.3,10490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10490,1,3,0)
 ;;=3^Nodular Episcleritis
 ;;^UTILITY(U,$J,358.3,10490,1,4,0)
 ;;=4^379.02
 ;;^UTILITY(U,$J,358.3,10490,2)
 ;;=^269285
 ;;^UTILITY(U,$J,358.3,10491,0)
 ;;=379.07^^52^596^90
 ;;^UTILITY(U,$J,358.3,10491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10491,1,3,0)
 ;;=3^Posterior Scleritis
 ;;^UTILITY(U,$J,358.3,10491,1,4,0)
 ;;=4^379.07
 ;;^UTILITY(U,$J,358.3,10491,2)
 ;;=^269295
 ;;^UTILITY(U,$J,358.3,10492,0)
 ;;=379.92^^52^596^106
 ;;^UTILITY(U,$J,358.3,10492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10492,1,3,0)
 ;;=3^Swelling/Mass of Eye
 ;;^UTILITY(U,$J,358.3,10492,1,4,0)
 ;;=4^379.92
 ;;^UTILITY(U,$J,358.3,10492,2)
 ;;=^269334
 ;;^UTILITY(U,$J,358.3,10493,0)
 ;;=379.93^^52^596^94
 ;;^UTILITY(U,$J,358.3,10493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10493,1,3,0)
 ;;=3^Redness/Discharge of Eye
